Premium
Private equity firm True North has sold a bulk of its stake in a drug research company, harvesting handsome gains from its second partial exit this year.It sold a 4.5% stake in Mumbai-listed Syngene International Ltd for Rs 427.50 crore ($65.8 million) through a block trade on Thursday, according to ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
